相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Hydroxychloroquine shortages among patients with systemic lupus erythematosus during the COVID-19 pandemic: experience of the Systemic Lupus International Collaborating Clinics
Arielle Mendel et al.
ANNALS OF THE RHEUMATIC DISEASES (2021)
Mechanisms of action of hydroxychloroquine and chloroquine: implications for rheumatology
Eva Schrezenmeier et al.
NATURE REVIEWS RHEUMATOLOGY (2020)
Baseline use of hydroxychloroquine in systemic lupus erythematosus does not preclude SARS-CoV-2 infection and severe COVID-19
Maximilian F. Konig et al.
ANNALS OF THE RHEUMATIC DISEASES (2020)
Of chloroquine and COVID-19
Franck Touret et al.
ANTIVIRAL RESEARCH (2020)
Guidance on Minimizing Risk of Drug-Induced Ventricular Arrhythmia During Treatment of COVID-19: A Statement from the Canadian Heart Rhythm Society
John L. Sapp et al.
CANADIAN JOURNAL OF CARDIOLOGY (2020)
Safety considerations with chloroquine, hydroxychloroquine and azithromycin in the management of SARS-CoV-2 infection
David N. Juurlink
CANADIAN MEDICAL ASSOCIATION JOURNAL (2020)
Effect of Chloroquine, Hydroxychloroquine, and Azithromycin on the Corrected QT Interval in Patients With SARS-CoV-2 Infection
Moussa Saleh et al.
CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY (2020)
Towards Optimization of Hydroxychloroquine Dosing in Intensive Care Unit COVID-19 Patients
Sophie Perinel et al.
CLINICAL INFECTIOUS DISEASES (2020)
In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
Xueting Yao et al.
CLINICAL INFECTIOUS DISEASES (2020)
Clinical evidence for repurposing chloroquine and hydroxychloroquine as antiviral agents: a systematic review
C. Rodrigo et al.
CLINICAL MICROBIOLOGY AND INFECTION (2020)
Optimizing Hydroxychloroquine Dosing for Patients With COVID-19: An Integrative Modeling Approach for Effective Drug Repurposing
Maria Garcia-Cremades et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2020)
IL-6: Relevance for immunopathology of SARS-CoV-2
E. O. Gubernatorova et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2020)
QT interval prolongation and torsade de pointes in patients with COVID-19 treated with hydroxychloroquine/azithromycin
Ehud Chorin et al.
HEART RHYTHM (2020)
QT prolongation, torsades de pointes, and sudden death with short courses of chloroquine or hydroxychloroquine as used in COVID-19: A systematic review
Lior Jankelson et al.
HEART RHYTHM (2020)
A review on possible modes of action of chloroquine/hydroxychloroquine: repurposing against SAR-CoV-2 (COVID-19) pandemic
Satyajit Tripathy et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2020)
Can post-exposure prophylaxis for COVID-19 be considered as an outbreak response strategy in long-term care hospitals?
Sun Hee Lee et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2020)
New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19?
Christian A. Devaux et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2020)
Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial
Philippe Gautret et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2020)
Prescription Fill Patterns for Commonly Used Drugs During the COVID-19 Pandemic in the United States
Muthiah Vaduganathan et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Analysis of the clinical characteristics, drug treatments and prognoses of 136 patients with coronavirus disease 2019
Qiuxiang Yang et al.
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS (2020)
Adverse drug reactions of hydroxychloroquine: Analysis of French pre-pandemic SARS-CoV2 pharmacovigilance data
Aurelie Grandvuillemin et al.
THERAPIE (2020)
Off-label use of hydroxychloroquine, azithromycin, lopinavir-ritonavir and chloroquine in COVID-19: A survey of cardiac adverse drug reactions by the French Network of Pharmacovigilance Centers
Alexandre Gerard et al.
THERAPIE (2020)
Chloroquine-induced QTc prolongation in COVID-19 patients
M. P. H. van den Broek et al.
NETHERLANDS HEART JOURNAL (2020)
Early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: A retrospective analysis of 1061 cases in Marseille, France
Matthieu Million et al.
TRAVEL MEDICINE AND INFECTIOUS DISEASE (2020)
Clinical and microbiological effect of a combination of hydroxychloroquine and azithromycin in 80 COVID-19 patients with at least a six-day follow up: A pilot observational study
Philippe Gautret et al.
TRAVEL MEDICINE AND INFECTIOUS DISEASE (2020)
Hydroxychloroquine in patients with mainly mild to moderate coronavirus disease 2019: open label, randomised controlled trial
Wei Tang et al.
BMJ-BRITISH MEDICAL JOURNAL (2020)
Clinical efficacy of hydroxychloroquine in patients with covid-19 pneumonia who require oxygen: observational comparative study using routine care data
Matthieu Mahevas et al.
BMJ-BRITISH MEDICAL JOURNAL (2020)
Cardiovascular Complications in Patients with COVID-19: Consequences of Viral Toxicities and Host Immune Response
Han Zhu et al.
CURRENT CARDIOLOGY REPORTS (2020)
Risk of QT Interval Prolongation Associated With Use of Hydroxychloroquine With or Without Concomitant Azithromycin Among Hospitalized Patients Testing Positive for Coronavirus Disease 2019 (COVID-19)
Nicholas J. Mercuro et al.
JAMA CARDIOLOGY (2020)
Review: Hydroxychloroquine and Chloroquine for Treatment of SARS-CoV-2 (COVID-19)
Katelyn A. Pastick et al.
OPEN FORUM INFECTIOUS DISEASES (2020)
Observational Study of Hydroxychloroquine in Hospitalized Patients with Covid-19
Joshua Geleris et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Finding the Dose for Hydroxychloroquine Prophylaxis for COVID-19: The Desperate Search for Effectiveness
Mahmoud Al-Kofahi et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2020)
An evidence mapping and analysis of registered COVID-19 clinical trials in China
Liming Lu et al.
BMC MEDICINE (2020)
Macrolides and viral infections: focus on azithromycin in COVID-19 pathology
Arianna Pani et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2020)
Incidence and determinants of QT interval prolongation in COVID-19 patients treated with hydroxychloroquine and azithromycin
Ilir Maraj et al.
JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY (2020)
Effect of High vs Low Doses of Chloroquine Diphosphate as Adjunctive Therapy for Patients Hospitalized With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection A Randomized Clinical Trial
Mayla Gabriela Silva Borba et al.
JAMA NETWORK OPEN (2020)
Association Between US Administration Endorsement of Hydroxychloroquine for COVID-19 and Outpatient Prescribing
James J. Harrigan et al.
JOURNAL OF GENERAL INTERNAL MEDICINE (2020)
Coalition: Advocacy for prospective clinical trials to test the post-exposure potential of hydroxychloroquine against COVID-19
Stephane Picot et al.
ONE HEALTH (2020)
COVID-19 and cardiac arrhythmias: a global perspective on arrhythmia characteristics and management strategies
Rakesh Gopinathannair et al.
JOURNAL OF INTERVENTIONAL CARDIAC ELECTROPHYSIOLOGY (2020)
撤稿声明: Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis (Retraction of 10.1016/S0140-6736(20)31180-6, 2020)
Mandeep R. Mehra et al.
LANCET (2020)
Urgent Guidance for Navigating and Circumventing the QTc-Prolonging and Torsadogenic Potential of Possible Pharmacotherapies for Coronavirus Disease 19 (COVID-19)
John R. Giudicessi et al.
MAYO CLINIC PROCEEDINGS (2020)
No evidence of rapid antiviral clearance or clinical benefit with the combination of hydroxychloroquine and azithromycin in patients with severe COVID-19 infection
J. M. Molina et al.
MEDECINE ET MALADIES INFECTIEUSES (2020)
Clinical trials for the prevention and treatment ofCOVID-19: current state of play
Joshua S. Davis et al.
MEDICAL JOURNAL OF AUSTRALIA (2020)
A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19
David R. Boulware et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
The risk of QTc-interval prolongation in COVID-19 patients treated with chloroquine
F. S. Sinkeler et al.
NETHERLANDS HEART JOURNAL (2020)
Characteristics of registered clinical trials assessing treatments for COVID-19: a cross-sectional analysis
Hemalkumar B. Mehta et al.
BMJ OPEN (2020)
Systematic review of registered trials of Hydroxychloroquine prophylaxis for COVID-19 healthcare workers at the first third of 2020
Anne-Lise Bienvenu et al.
ONE HEALTH (2020)
Endpoints used in phase III randomized controlled trials of treatment options for COVID-19
Aakash Desai et al.
ECLINICALMEDICINE (2020)
Clinical course of coronavirus disease 2019 (COVID-19) in a series of 17 patients with systemic lupus erythematosus under long-term treatment with hydroxychloroquine
Alexis Mathian et al.
ANNALS OF THE RHEUMATIC DISEASES (2020)
Repurposing old drugs in oncology: Opportunities with clinical and regulatory challenges ahead
Rashmi R. Shah et al.
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS (2019)
Heart Rate-corrected QT Interval Duration in Rheumatoid Arthritis and Its Reduction with Treatment with the Interleukin 6 Inhibitor Tocilizumab
Hitomi Kobayashi et al.
JOURNAL OF RHEUMATOLOGY (2018)
Interleukin-6 inhibition of hERG underlies risk for acquired long QT in cardiac and systemic inflammation
Ademuyiwa S. Aromolaran et al.
PLOS ONE (2018)
Systemic inflammation as a novel QT-prolonging risk factor in patients with torsades de pointes
Pietro Enea Lazzerini et al.
HEART (2017)
Effects of statins on cancer mortality and progression: A systematic review and meta-analysis of 95 cohorts including 1,111,407 individuals
Zubing Mei et al.
INTERNATIONAL JOURNAL OF CANCER (2017)
Azithromycin Causes a Novel Proarrhythmic Syndrome
Zhenjiang Yang et al.
CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY (2017)
Drug repositioning and repurposing: terminology and definitions in literature
Joris Langedijk et al.
DRUG DISCOVERY TODAY (2015)
Association Between Corrected QT Interval and Inflammatory Cytokines in Rheumatoid Arthritis
Ahmed M. Adlan et al.
JOURNAL OF RHEUMATOLOGY (2015)
Azithromycin, cardiovascular risks, QTc interval prolongation, torsade de pointes, and regulatory issues: A narrative review based on the study of case reports
Jules C. Hancox et al.
THERAPEUTIC ADVANCES IN INFECTIOUS DISEASE (2013)
Discovering Thiamine Transporters as Targets of Chloroquine Using a Novel Functional Genomics Strategy
Zhiwei Huang et al.
PLOS GENETICS (2012)
Reversal of chemoresistance and enhancement of apoptosis by statins through down-regulation of the NF-κB pathway
Kwang Seok Ahn et al.
BIOCHEMICAL PHARMACOLOGY (2008)
Statins and cancer: A systematic review and meta-analysis
Jaana Kuoppala et al.
EUROPEAN JOURNAL OF CANCER (2008)
Simvastatin induces apoptosis in human colon cancer cells and in tumor xenografts, and attenuates colitis-associated colon cancer in mice
Soo-Jeong Cho et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
Recycling of chloroquine and its hydroxyl analogue to face bacterial, fungal and viral infections in the 21st century
Jean-Marc Rolain et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2007)
In vitro inhibition of severe acute respiratory syndrome coronavirus by chloroquine
E Keyaerts et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)
HMG-CoA reductase inhibitors and the malignant cell: the statin family of drugs as triggers of tumor-specific apoptosis
WWL Wong et al.
LEUKEMIA (2002)
分享论文
